Analysis

Skip to filters. View results.

What’s new on our website

View results
Sort Help
entries

Results

All (54)

All (54) (0 to 10 of 54 results)

  • 1. Innovators, Non-innovators and Venture Firms: What Is the Nature of Firms in Research and Development Services Industries? Archived
    Articles and reports: 88F0006X2007007
    Description:

    Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.

    This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.

    Release date: 2007-12-20
  • 2. Selected Results of the Biotechnology Use and Development Survey 2005 Archived
    Articles and reports: 88F0006X2007006
    Description:

    This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.

    Release date: 2007-12-05
  • 3. Results of the pilot survey on nanotechnologies Archived
    Articles and reports: 88-003-X200700210323
    Geography: Canada
    Description:

    Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.

    Release date: 2007-10-09
  • 4. International activities on the development of nanotechnology statistics Archived
    Articles and reports: 88-003-X200700210324
    Geography: Canada
    Description:

    Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.

    Release date: 2007-10-09
  • 5. Firm characteristics and fund-raising activities of biotech firms in Canada Archived
    Articles and reports: 88-003-X200700210325
    Geography: Canada
    Description:

    Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.

    Release date: 2007-10-09
  • 6. Start-up funding sources and biotechnology firm growth Archived
    Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09
  • 7. Overview and Discussion of the Results of the Pilot Survey on Nanotechnology in Canada Archived
    Articles and reports: 88F0006X2007005
    Description:

    This working paper provides results from a pilot survey on nanotechnology, which was appended to the Biotechnology Use and Development Survey 2005. The paper presents the conceptual issues and survey challenges relating to measurement of nanotechnology-related activities, as well as preliminary data on nanotechnology firms in Canada.

    Release date: 2007-08-31
  • 8. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey Archived
    Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10
  • 9. Research and development services in physical, engineering and life sciences (PELS): Why do so many establishments say that satisfying existing clients is not relevant to their success? Archived
    Articles and reports: 88-003-X20060029246
    Geography: Canada
    Description:

    While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.

    Release date: 2006-06-27
  • 10. Canadian biotechnology activity, 2003 Archived
    Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20
Stats in brief (0)

Stats in brief (0) (0 results)

No content available at this time.

Articles and reports (54)

Articles and reports (54) (30 to 40 of 54 results)

  • 31. Distribution of biotechnology innovator firms in Canada, 2001 Archived
    Articles and reports: 88-003-X20030016474
    Geography: Canada, Province or territory
    Description:

    In 2001, there were 375 biotechnology innovator firms in Canada, an increase of just under 5% from the 358 firms in 1999. Analysis beyond these overall statistics discloses a dynamic churning that is occurring among sectors, provinces and size groups.

    Release date: 2003-02-18
  • 32. Characteristics and evolution of human resources in Canadian biotechnology firms Archived
    Articles and reports: 88-003-X20030016475
    Geography: Canada
    Description:

    Data from the 2001 Biotechnology Use and Development Survey show that human resources in biotechnology increased substantially between 1999 and 2001. In this article, we attempt to answer two questions: What are the characteristics of the human resources engaged in the biotechnology field in Canada? Moreover, what are the main factors that contributed to the growth of these human resources in 2001?

    Release date: 2003-02-18
  • 33. Coming of age - biotech revenues are on the rise Archived
    Articles and reports: 88-003-X20030016476
    Geography: Canada
    Description:

    Canadian biotechnology is gaining momentum. More firms are getting their products onto the markets and increasing revenues. With the human health sector leading the way, biotechnology revenues rose by a massive 343% for the 1997 to 2001 period, reaching $3.5 billion in 2001. During this same period, the number of firms increased by 33%.

    Release date: 2003-02-18
  • 34. Use of Biotechnologies in the Canadian Industrial Sector: Results from the Biotechnology Use and Development Survey - 1999 Archived
    Articles and reports: 88F0006X2002003
    Description:

    This is the final of three papers providing data and an overview of the results of the Biotechnology Use and Development Survey - 1999. Readers are encouraged to use the data. The next edition of the Biotechnology Use and Development Survey - 2001 is expected to be administered in the spring of 2002 with results available early in 2003.

    Release date: 2002-03-28
  • 35. Profile of Spin-off Firms in the Biotechnology Sector: Results from the Biotechnology Use and Development Survey - 1999 Archived
    Articles and reports: 88F0006X2002004
    Description:

    Spin-off firms made up over 34% of the core group of firms from the 1999 biotechnology survey. They also made up over 112 of the 270 small (under 50 employees) size firms, by far the largest group of core biotechnology, and half of the human health related firms, the largest sector of biotechnology firms. Central to this paper is the question: What are the general characteristics of this sub-group of core biotechnology firms?

    Release date: 2002-03-28
  • 36. We have learned a great deal! Archived
    Articles and reports: 88-003-X20020016146
    Geography: Canada
    Description:

    This, the first issue of 2002 presents an opportunity to recapitulate some of the findings that we have reported during the life of the Bulletin. In an interview, Dr. Fred Gault, Director of Statistics Canada's Science, Innovation and Electronic Information Division, discusses some of the findings on innovation, e-commerce, emerging technologies, Internet use, the telecommunications industry, R&D and commercialization.

    Release date: 2002-02-15
  • 37. A profile of spin-off firms in the biotechnology sector Archived
    Articles and reports: 88-003-X20020016149
    Geography: Canada
    Description:

    According to the report Profile of Spin-off Firms in the Biotechnology Sector, three out of every 10 companies in Canada's rapidly expanding biotechnology sector in 1999 were spin-offs. These firms, which range from corporate spin-offs to biotechnology companies created by universities and research hospitals, accounted for more than one-quarter of total revenues in 1999.

    Release date: 2002-02-15
  • 38. Use of biotechnologies by Canadian biotechnology firms Archived
    Articles and reports: 88-003-X20010035970
    Geography: Canada
    Description:

    This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.

    Release date: 2001-10-31
  • 39. Selected strategies and practices of Canadian biotechnology firms: Results from the Biotechnology Use and Development Survey - 1999 Archived
    Articles and reports: 88-003-X20010035971
    Geography: Canada
    Description:

    Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.

    Release date: 2001-10-31
  • 40. Canadian biotech firms: Extent of networking activities and commercialization obstacles Archived
    Articles and reports: 88-003-X20010035972
    Geography: Canada
    Description:

    Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?

    Release date: 2001-10-31
Journals and periodicals (0)

Journals and periodicals (0) (0 results)

No content available at this time.

Report a problem or mistake on this page
Date modified:

Search help

How do I use the filters and the search box?

  • You can initiate a search by entering keywords or selecting filters (e.g., under Subject, Geography, etc.) on the left side of the page.

  • Filters can be used together or in any combination. Each time you select a filter, the results on the page are updated.

  • To start a new search, click on the Clear all button above the search box or deselect each filter.

  • Specified keywords and filters appear above the search box. You can deselect any or all the tags to refine or clear your search.

How do I refine my search?

  • You can enter keywords in the search box. It is not necessary to use “+” or “, “ or “AND”.

  • You can delete some or all of the keywords from your search string.

  • Quotes around keywords limit the search to a specific phrase.

    • For example, “labour force survey” will limit results to products containing this phrase.

  • Use “or” between keywords to obtain results that contain one or more search terms.

    • For example, labour or­ force or survey will limit results to products containing any or all of these words.

How does the search work?

  • This search looks for results that have your query term in the title, description, subject, geography, product number or other information about the product.

    • For example, when searching the term ‘Diseases’, all results with the word ‘Diseases’ in the title, description or tagged the subject appear.

  • The text within an article or publication are not searched. For full text searching of articles, use the site search.

Sort help

How are the results ordered?

The Sort by feature provides three options:

  • By date – sorts results by product release date starting with the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.

Sort help

How are the results ordered?

The Sort by feature provides four options:

  • By date – sorts results by product release date starting with the most recent.
  • By most popular – gives priority to results that are most frequently selected by users, followed by the most recent.
  • By relevance is only needed or beneficial when you use the search box and submit a search query. Results are ordered by a combination of where the search term appears in the content, e.g., if it appears in the title, it likely means the product is more relevant to your search; how up to date or new the content in the product is; how popular the product is; and other factors.
  • By title – sorts results alphabetically.